Skip to main content

How Gut Bacteria May Predict Preterm Birth

Scientists linked a maternal gut microbe that degrades key pregnancy hormones to early labor, potentially serving as a predictive risk biomarker.

Written byLaura Tran, PhD
| 2 min read
Image of a preterm baby in the neonatal section of the maternity ward.
Register for free to listen to this article
Listen with Speechify
0:00
2:00

During pregnancy, expectant mothers often take steps to prepare for the arrival of their baby, such as taking vitamins and supplements and avoiding smoking or alcohol. While a typical pregnancy lasts about 40 weeks, preterm birth—defined as birth before 37 weeks of gestation—can occur and is the leading cause of neonatal and under-five mortality worldwide.1

Although much research has focused on the vaginal microbiome and its potential connection to preterm birth, the role of the gut microbiome remains less understood. This gap in knowledge motivated a group of researchers in China to explore the maternal gut microbiome more closely and assess its potential link to preterm birth.

In a recent study, published in Cell Host & Microbe, the team identified maternal gut microbes associated with a higher risk of preterm birth during early pregnancy, especially those that can degrade estradiol, an important pregnancy hormone.2 The researchers hope to further explore this association of estradiol-degrading bacteria as potential predictive biomarkers for preterm birth.

First, the researchers gathered stool and blood samples from two groups of pregnant women—one in early pregnancy and the other in mid-pregnancy. Using metagenome and 16S rRNA sequencing, the team identified similar gut microbiota profiles across the women. From this, they found five prevalent genera: Blautia, Faecalibacterium, Bacteroides, Anaerostipes, and Streptococcus. At the same time, they tracked each woman's preterm delivery status.

Continue reading below...

Like this story? Sign up for FREE Microbiology updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

The researchers then turned to statistical models to dive deeper into the relationship between the gut microbiota and factors like gestational duration and preterm birth. Their analysis uncovered 11 specific genera linked to these outcomes, but one species stood out: Clostridium innocuum. This bacterium had the strongest connection to preterm birth.

Intrigued by C. innocuum, the team investigated its role in sex hormone metabolism and found that it makes an enzyme that degrades estradiol, a hormone important in pregnancy. To explore this further, they tested the bacterium’s estradiol degrading ability in female mice across different gestational periods (from early pregnancy to having a near-term fetus) and found that doses of C. innocuum significantly reduced estradiol levels by converting it into estrone. Additional analysis revealed key enzymes in the bacterium that played a critical role in this process.

Because of these findings, the researchers hypothesize that a high prevalence of C. innocuum may dysregulate estradiol levels and increase the risk of preterm birth. However, the team also acknowledged that scientists would need to evaluate more cohorts to validate these findings in broader populations.

“This study suggests that for pregnant women or women preparing to become pregnant, it may be important to monitor their gut microbiome to prevent potential adverse pregnancy outcomes,” said study coauthor An Pan, an epidemiologist at Huazhong University of Science and Technology in a press release.

Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Laura Tran, PhD

    Laura Tran is an Associate Editor, Content & Newsletters at The Scientist. She has a background in microbiology. Laura earned her PhD in integrated biomedical sciences from Rush University, studying how circadian rhythms and alcohol impact the gut. While completing her studies, she wrote for the Chicago Council on Science and Technology and participated in ComSciCon Chicago in 2022. In 2023, Laura became a science communication fellow with OMSI, continuing her passion for accessible science storytelling.

    View Full Profile

Related Topics

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo